LH stock forecast
Our latest prediction for Laboratory Corp. of America Holdings's stock price was made on the Oct. 28, 2019 when the stock price was at 163.82$.
In the short term (2weeks), LH's stock price should outperform the market by 0.27%. During that period the price should oscillate between -2.59% and +3.67%.
In the medium term (3months), LH's stock price should outperform the market by 0.34%. During that period the price should oscillate between -5.91% and +9.34%.Get email alerts
About Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.
At the moment the company generates 11388M USD in revenues.
On its last earning announcement, the company reported a profit of 7.61$ per share.
The book value per share is 69.06$
Three months stock forecastOct. 28, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|